Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)
Jean-Claude Ansquer, Christelle Foucher, Stephanie Rattier, Marja-Riitta Taskinen, George SteinerVolume:
45
Année:
2005
Langue:
english
Pages:
9
DOI:
10.1053/j.ajkd.2004.11.004
Fichier:
PDF, 173 KB
english, 2005